Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphoea by severity and identify clinically significant change

Summary Background Validated scoring measures in morphoea can facilitate clinical trials. Objectives To ascertain the clinical significance of scores on the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) and identify the change in scores correlated with clinically meaningful change. Method...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of dermatology (1951) 2020-02, Vol.182 (2), p.398-404
Hauptverfasser:	Teske, N.M., Jacobe, H.T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Child Clinical significance Clinical trials Cohort Studies Humans Prospective Studies Reproducibility of Results Scleroderma Scleroderma, Localized - diagnosis Severity of Illness Index
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!